Low-Dose Atropine for Myopia Control-Reply

Qianwen Gong¹, Miroslaw Janowski^{2

3}, Longqian Liu^{1

4}

Affiliations

¹ Department of Optometry and Visual Science, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China.
² Division of MR Research, Department of Radiology and Radiological Science, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland.
³ NeuroRepair Department, Mossakowski Medical Research Centre PAS, Warsaw, Poland.
⁴ Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Comment

Qianwen Gong et al. JAMA Ophthalmol. 2018.

. 2018 Mar 1;136(3):303-304.

doi: 10.1001/jamaophthalmol.2017.6641.

Qianwen Gong¹, Miroslaw Janowski^{2

3}, Longqian Liu^{1

4}

¹ Department of Optometry and Visual Science, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China.
² Division of MR Research, Department of Radiology and Radiological Science, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland.
³ NeuroRepair Department, Mossakowski Medical Research Centre PAS, Warsaw, Poland.
⁴ Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

No abstract available

Comment on

Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.
Gong Q, Janowski M, Luo M, Wei H, Chen B, Yang G, Liu L. Gong Q, et al. JAMA Ophthalmol. 2017 Jun 1;135(6):624-630. doi: 10.1001/jamaophthalmol.2017.1091. JAMA Ophthalmol. 2017. PMID: 28494063 Free PMC article. Review.
Low-Dose Atropine for Myopia Control: Considering All the Data.
Bullimore MA, Berntsen DA. Bullimore MA, et al. JAMA Ophthalmol. 2018 Mar 1;136(3):303. doi: 10.1001/jamaophthalmol.2017.6638. JAMA Ophthalmol. 2018. PMID: 29423500 No abstract available.